From: ISO 10993 biological evaluation of novel hemostatic powder – 4SEAL®
Group | albumin | ALP | ALT | AST | Ca | Cl | Cholesterol | Creatinine |
---|---|---|---|---|---|---|---|---|
[g/dL] | [U/L] | [U/L] | [U/L] | [mg/dL] | [mmol/L] | [mg/dL] | [mg/dL] | |
Negative control - female | 4.12 | 257.00 | 38.80 | 154.80 | 9.46 | 102.20 | 69.00 | 0.21 |
4SEAL® - female | 3.78 | 236.00 | 43.40 | 97.60 | 9.92 | 102.00 | 73.60 | 0.17 |
Negative control – male | 3.36 | 245.80 | 44.20 | 81.40 | 10.28 | 98.40 | 73.00 | 0.20 |
4SEAL® - male | 3.34 | 247.00 | 43.80 | 86.80 | 10.44 | 97.00 | 62.00 | 0.13 |